Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole vs Ziprasidone for Cardiovascular Risk in Schizophrenia
NCT00288353Phase 3Terminated
- Sponsor
- Northwestern University
- Start
- Jan 2006
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aripiprazole, ziprasidone in schizophrenia, schizoaffective disorder, bipolar disorder (BD), sponsored by Northwestern University. Started Jan 2006; status: terminated.
02
Drugs
aripiprazoleziprasidone
03
Conditions
schizophreniaschizoaffective disorderbipolar disorder (BD)
Beyond the preview
Go deeper on NCT00288353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00288353.